Lv1
40 积分 2022-10-12 加入
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives
4天前
已完结
FDA approvals for pediatric cancer indications using children’s oncology group associated trials data
4天前
已完结
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
10天前
已完结
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
15天前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
15天前
已完结
Testicular Germ Cell Tumors
23天前
已完结
Long-term trends and disparities in primary intracranial germ cell tumor incidence and mortality for child and adolescent in the USA
23天前
已完结
Hepatoblastoma
23天前
已完结
KN046, a bispecific antibody against PD-L1 and CTLA-4, plus chemotherapy as first-line treatment for metastatic NSCLC: A multicenter phase 2 trial
3个月前
已完结
Brief report: Ivonescimab combined with etoposide plus carboplatin as first-line treatment for extensive-stage small-cell lung cancer: results of a phase Ib clinical trial
5个月前
已完结
皖公网安备34019202002308
